P. Limburg

发表

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.

H. Groen, N. Mulder, E. de Vries, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.